-
NMPA holds special training program on quality improvement of vaccines, blood products
On April 10, the National Medical Products Administration (NMPA) convened a special public training program, with online and on-site participation, on inspection, rectification and quality improvement of vaccines and blood products in order to further reinforce oversight of the quality and safety of these medical products.
-
Yang Sheng meets with associate commissioner for global policy and strategy of US FDA
On Jan 27, Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA) of China, met with a visiting delegation led by Mark Abdoo, associate commissioner for global regulatory operations and policy of the US Food and Drug Administration (FDA).
-
China revises drug administration regulations to spur innovation, tighten oversight
China has revised regulations concerning drug administration in a bid to promote drug innovation, strengthen management of online sales of medicines and reinforce drug safety supervision.
- Announcement of the National Medical Products Administration on Strengthening Supervision and Administration of Contract Manufacturing of Drugs (No. 134, 2025)
- Announcement of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers([2025] No. 113)
- Policy Interpretation of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers
- Announcement of the National Medical Products Administration on Strengthening Supervision and Administration of Contract Manufacturing of Drugs (No. 134, 2025)
- Policy Interpretation of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers
- Announcement of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers([2025] No. 113)
